Business Wire

IL-NIELSENIQ

24.7.2024 16:01:26 CEST | Business Wire | Press release

Share
NIQ Releases 2023 Environment, Social and Governance (ESG) Progress Report

NielsenIQ (NIQ), the world’s leading consumer intelligence company, has released its second Environmental, Social and Governance (ESG) Progress Report detailing the Company’s ESG priorities, how it embeds inclusive, sustainable principles into its business model and its commitment to delivering intelligence and innovation to customers that positively impact economies, communities, and the environment.

“Our ESG strategy is designed to drive long-term value — for our employees, our stakeholders, our customers, our industry, our vendors, and our communities,” said Jim Peck, Chief Executive Officer, NIQ. "We are focused on integrating our ESG priorities company-wide and increasing our impact. Additionally, by providing a thorough understanding of consumer purchasing behavior, we aim to offer market intelligence to our clients and their ecosystems to support their sustainability efforts."

Notable highlights in the 2023 ESG Report:

Data Integrity, Privacy & Security
Data is at the core of NIQ’s business. The company is focused on delivering secure and protected data with a high-level of precision and integrity.

  • Ensuring Data Integrity: NIQ takes measures to ensure that data is accurate and relevant. In the past year, NIQ has established a dedicated Generative AI taskforce that explores next-generation AI applications, with an emphasis on data quality, completeness, and ethical considerations. It also has established quality checks for field data collection, including having strict controls in place for field auditors to ensure high integrity and an incident response plan so that deviations from standard practices can immediately be addressed.
  • Fortifying and Securing NIQ’s Data: NIQ has robust practices to identify and address data security risks. To identify vulnerabilities, NIQ conducts regular vulnerability scanning and assessments of all information systems. To address them, NIQ has a cybersecurity team that implements multiple layers of organizational, technical, and administrative measures to protect data.
  • Prioritizing Data Privacy: NIQ follows a comprehensive set of privacy principles, which include user-friendly privacy controls, clear notice, and choice options. In addition to complying with laws and industry standards in the countries in which it operates, NIQ incorporates privacy safeguards directly into the design and implementation of NIQ products and services.
  • Safeguarding NIQ’s Digital Future. NIQ is prioritizing seamless security integration throughout the organization, focusing on its people, data privacy, and confidentiality. The ongoing Cybersecurity and Privacy Program unifies global departments, leveraging NIST CSF and ISO 27002 standards.

Environmental Responsibility

  • Pioneering Sustainable Impact. With a commitment to help shape marketplaces, NIQ collaborates with clients to encourage transition to more sustainable products by reflecting the evolving conscious consumer trends. In 2023, NIQ partnered with McKinsey & Company to develop a report titled “Consumers care about sustainability – and back it up with their wallets”.
  • NIQ has adopted a data driven approach to measuring carbon footprint, and measured carbon footprint for a second year in 2022.
  • NIQ works closely with vendors and partners to select energy-efficient lease properties and investigate opportunities to implement clean energy and energy-reduction initiatives.
  • NIQ has optimized its data centers to reduce energy use, with approximately 90% of NIQ’s servers being virtualized in 2022, resulting in significant energy savings.
  • For a decade, NIQ has provided Feeding America® with data, insights, and expertise, including local food pricing data to estimate meal costs in every U.S. County for Map the Meal Gap report. This report raises awareness of food insecurity across the U.S. and is used by food banks and policymakers.

People & Diversity, Equity, and Inclusion

  • Continuing to improve the diversity of its workforce. NIQ is committed to building a diverse workforce, equitable processes, and an inclusive culture aligned with its core values.
    • Minority group members now serve in 29% of roles across the organization and women serve in half of the workforce, with over 43% female representation in global leadership positions.
    • In 2023, NIQ renewed its LEAD Network Europe CEO Pledge to further accelerate gender parity and to prioritize gender equity.
  • Embracing Diversity, Equity, and Inclusion. As part of its integration efforts with GfK, NIQ has made a conscious effort to understand its unique company culture and to foster a combined environment that promotes inclusion in all areas of the company. NIQ has strongly encouraged cross-entity internal hiring, so associates can develop their careers and realize their aspirations, and as of August 2023, NIQ has posted more than 500 open roles for internal applicants in NIQ and GfK.
  • Extending People & Planet Day. During its second annual People & Planet Day, 13,000 global employees contributed to local volunteer efforts, participating in various activities. Overall, NIQ contributed over 75,000 hours, covering more than 500 activities, with nearly $67,000 in employee fundraising. This was a combined activity for legacy NIQ and legacy GfK associates.

“NIQ data can help companies and communities make informed decisions that ultimately help grow their business sustainably and support communities that they serve,” said John Blenke, Chief Legal Officer. “We are proud of our ESG efforts to date and look forward to scale our positive impact through continued progress.”

NIQ aligns ESG reporting with the UN Sustainable Development Goals and the Sustainability Accounting Standards Board (SASB) Standards for Professional Commercial Services. To learn more about NIQ’s approach to ESG, the company’s continued commitment to creating value for society and its progress on key goals, please visit the NIQ’s 2023 ESG Progress Report.

About NIQ

NielsenIQ (NIQ) is the world’s leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. NIQ combined with GfK in 2023, bringing together the two industry leaders with unparalleled global reach. Today NIQ has operations in more than 95 countries covering 97% of GDP. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View™.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240724714892/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye